Search

Search Results
Results 5811 - 5820 of 5863 for Mental illness
  • Diaformin XR (new formulation)
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Diaformin XR (new formulation) intended for persons living in Australia.
  • Diabex XR 500 and 1000
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Diabex
    Drug - 14 Oct 2022
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Mizart
    Drug - 10 Oct 2022
    Consumer Medicine Information (CMI) about Mizart (Telmisartan) intended for persons living in Australia.
  • Jardiamet
    Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Jardiamet (empagliflozin / metformin hydrochloride) intended for persons living in Australia.
  • Dothep
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dothep intended for persons living in Australia.
  • Dosulepin Viatris (formerly Dosulepin Mylan)
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dosulepin Viatris (formerly Dosulepin Mylan) intended for persons living in Australia.
  • Diflucan IV
    Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Diflucan IV intended for persons living in Australia.
  • Diflucan
    Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Diflucan intended for persons living in Australia.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback